SH3PXD2B
Basic information
Region (hg38): 5:172325000-172454525
Previous symbols: [ "KIAA1295" ]
Links
Phenotypes
GenCC
Source:
- Frank-Ter Haar syndrome (Definitive), mode of inheritance: AR
- Frank-Ter Haar syndrome (Strong), mode of inheritance: AR
- Frank-Ter Haar syndrome (Strong), mode of inheritance: AR
- Frank-Ter Haar syndrome (Supportive), mode of inheritance: AR
- Frank-Ter Haar syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Frank-ter Haar syndrome | AR | Cardiovascular; Ophthalmologic; Pharmacogenomic | The condition may be clinically recognizable, but can include macrocornea with or without glaucoma, and surveillance and prompt treatment may be beneficial; Awareness of cardiac anomalies may allow prompt management; Agents that may contribute to glaucoma should be avoided | Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 4805907; 7158646; 9375925; 9188664; 15523657; 20137777; 24105366 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
- Frank-Ter Haar syndrome (1 variants)
- SH3PXD2B-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SH3PXD2B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 74 | 84 | ||||
missense | 156 | 16 | 178 | |||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 7 | |||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 7 | 2 | 11 | ||
non coding | 82 | 59 | 73 | 214 | ||
Total | 4 | 4 | 250 | 150 | 86 |
Highest pathogenic variant AF is 0.00000657
Variants in SH3PXD2B
This is a list of pathogenic ClinVar variants found in the SH3PXD2B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-172325268-C-G | SH3PXD2B-related disorder | Likely benign (Jun 05, 2020) | ||
5-172325312-T-C | SH3PXD2B-related disorder | Likely benign (Feb 04, 2021) | ||
5-172333540-TA-T | Frank-Ter Haar syndrome | Benign (Jun 14, 2016) | ||
5-172333540-T-TA | Frank-Ter Haar syndrome | Uncertain significance (Jun 14, 2016) | ||
5-172333541-A-T | Frank-Ter Haar syndrome | Benign (Jan 12, 2018) | ||
5-172333542-A-T | Frank-Ter Haar syndrome | Benign (Jan 12, 2018) | ||
5-172333564-C-T | Frank-Ter Haar syndrome | Uncertain significance (Jan 12, 2018) | ||
5-172333565-A-G | Frank-Ter Haar syndrome | Benign (Jan 12, 2018) | ||
5-172333596-C-G | Frank-Ter Haar syndrome | Uncertain significance (Jan 15, 2018) | ||
5-172333633-T-C | Frank-Ter Haar syndrome | Uncertain significance (Jan 12, 2018) | ||
5-172333676-G-A | Frank-Ter Haar syndrome | Uncertain significance (Jan 12, 2018) | ||
5-172333700-AGAGT-A | Frank-Ter Haar syndrome | Uncertain significance (Jun 14, 2016) | ||
5-172333808-C-T | Frank-Ter Haar syndrome | Uncertain significance (Jan 12, 2018) | ||
5-172333880-G-A | Frank-Ter Haar syndrome | Uncertain significance (Jan 12, 2018) | ||
5-172333949-T-C | Frank-Ter Haar syndrome | Uncertain significance (Jan 13, 2018) | ||
5-172334041-G-A | Frank-Ter Haar syndrome | Uncertain significance (Jan 12, 2018) | ||
5-172334086-C-T | Frank-Ter Haar syndrome | Uncertain significance (Jan 12, 2018) | ||
5-172334103-C-A | Frank-Ter Haar syndrome | Uncertain significance (Jan 13, 2018) | ||
5-172334267-C-A | Frank-Ter Haar syndrome | Uncertain significance (Jan 12, 2018) | ||
5-172334290-G-A | Frank-Ter Haar syndrome | Uncertain significance (Jan 13, 2018) | ||
5-172334334-C-T | Frank-Ter Haar syndrome | Benign (Jan 13, 2018) | ||
5-172334380-C-T | Frank-Ter Haar syndrome | Likely benign (Jan 13, 2018) | ||
5-172334433-C-T | Frank-Ter Haar syndrome | Benign (Jan 13, 2018) | ||
5-172334434-G-A | Frank-Ter Haar syndrome | Uncertain significance (Jan 13, 2018) | ||
5-172334511-C-G | Frank-Ter Haar syndrome | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SH3PXD2B | protein_coding | protein_coding | ENST00000311601 | 13 | 129343 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00416 | 0.996 | 125568 | 0 | 180 | 125748 | 0.000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.526 | 511 | 546 | 0.937 | 0.0000347 | 5925 |
Missense in Polyphen | 159 | 204.39 | 0.77791 | 2252 | ||
Synonymous | 0.830 | 213 | 229 | 0.930 | 0.0000162 | 1817 |
Loss of Function | 4.08 | 12 | 39.8 | 0.301 | 0.00000198 | 465 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000702 | 0.000698 |
Ashkenazi Jewish | 0.00566 | 0.00567 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000555 | 0.000554 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.000555 | 0.000555 |
Other | 0.00212 | 0.00212 |
dbNSFP
Source:
- Function
- FUNCTION: Adapter protein involved in invadopodia and podosome formation and extracellular matrix degradation. Binds matrix metalloproteinases (ADAMs), NADPH oxidases (NOXs) and phosphoinositides. Acts as an organizer protein that allows NOX1- or NOX3-dependent reactive oxygen species (ROS) generation and ROS localization. Plays a role in mitotic clonal expansion during the immediate early stage of adipocyte differentiation (By similarity). {ECO:0000250, ECO:0000269|PubMed:12615925, ECO:0000269|PubMed:19755710, ECO:0000269|PubMed:20609497}.;
- Disease
- DISEASE: Frank-Ter Haar syndrome (FTHS) [MIM:249420]: A syndrome characterized by brachycephaly, wide fontanels, prominent forehead, hypertelorism, prominent eyes, macrocornea with or without glaucoma, full cheeks, small chin, bowing of the long bones and flexion deformity of the fingers. {ECO:0000269|PubMed:20137777}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.628
- rvis_EVS
- -0.28
- rvis_percentile_EVS
- 33.57
Haploinsufficiency Scores
- pHI
- 0.262
- hipred
- N
- hipred_score
- 0.462
- ghis
- 0.556
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.128
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sh3pxd2b
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; vision/eye phenotype; craniofacial phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype;
Gene ontology
- Biological process
- skeletal system development;eye development;osteoblast fate commitment;superoxide metabolic process;heart development;positive regulation of gene expression;extracellular matrix disassembly;positive regulation of multicellular organism growth;positive regulation of catalytic activity;positive regulation of fat cell differentiation;skeletal system morphogenesis;positive regulation of stress fiber assembly;bone development;regulation of brood size;adipose tissue development;podosome assembly;protein localization to membrane;positive regulation of adipose tissue development;cranial skeletal system development
- Cellular component
- podosome;cytoplasm;cell junction;cell projection
- Molecular function
- protein binding;phosphatidylinositol-5-phosphate binding;superoxide-generating NADPH oxidase activator activity;phosphatidylinositol-3-phosphate binding;phosphatidylinositol binding;SH2 domain binding;phosphatidylinositol-4-phosphate binding;phosphatidylinositol-3,5-bisphosphate binding